United Therapeutics Corp (UTHR)

125.71
5.20 4.30
NASDAQ : Health Care
Prev Close 120.50
Open 121.21
Day Low/High 120.11 / 125.89
52 Wk Low/High 97.52 / 175.66
Volume 291.05K
Avg Volume 627.50K
Exchange NASDAQ
Shares Outstanding 44.96M
Market Cap 5.39B
EPS 14.20
P/E Ratio 8.39
Div & Yield N.A. (N.A)

Latest News

Biotech Movers: Novocure, United Therapeutics, Kite Pharma

Biotech Movers: Novocure, United Therapeutics, Kite Pharma

Novocure, United Therapeutics and Kite Pharma were among the biotech stock movers in early trading Monday.

United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump

United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump

Conference Call Scheduled for 9:00 AM on April 3, 2017

United Therapeutics Stock Slumping on Credit Suisse Rating

United Therapeutics Stock Slumping on Credit Suisse Rating

Credit Suisse initiated United Therapeutics with an 'underperform' rating.

Analysts' Actions -- FedEx, GoPro, Garmin, HP and More

Analysts' Actions -- FedEx, GoPro, Garmin, HP and More

Here are Monday's top research calls, including upgrades for FedEx, Garmin and HP, and a downgrade for GoPro.

Short Interest In United Therapeutics Declines 12.2%

Short Interest In United Therapeutics Declines 12.2%

The most recent short interest data has been released for the 01/13/2017 settlement date, which shows a 889,891 share decrease in total short interest for United Therapeutics Corp , to 6,429,430, a decrease of 12.16% since 12/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

United Therapeutics Stock Sees Short Interest Move 13% Lower

United Therapeutics Stock Sees Short Interest Move 13% Lower

The most recent short interest data has been released for the 12/30/2016 settlement date, which shows a 1,081,454 share decrease in total short interest for United Therapeutics Corp , to 7,319,321, a decrease of 12.87% since 12/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios

Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.

Storm The Castle: United Therapeutics (UTHR)

Storm The Castle: United Therapeutics (UTHR)

Trade-Ideas LLC identified United Therapeutics (UTHR) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

United Therapeutics Corporation Announces Executive Leadership Changes

United Therapeutics Corporation Announces Executive Leadership Changes

- Roger Jeffs, Ph.D. steps down as President and Co-Chief Executive Officer

United Therapeutics Has Room to Fall Farther

With the weekly close under the $120 support level, the next chart support lies around $90 -- the lows of 2014.

Today's Dead Cat Bounce Stock: United Therapeutics (UTHR)

Today's Dead Cat Bounce Stock: United Therapeutics (UTHR)

Trade-Ideas LLC identified United Therapeutics (UTHR) as a "dead cat bounce" (down big yesterday but up big today) candidate

3 Stocks Pushing The Drugs Industry Downward

3 Stocks Pushing The Drugs Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.